Theralase Technologies (TLT) Hits New 52-Week High at $0.50

Theralase Technologies Inc. (CVE:TLT)’s share price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as C$0.50 and last traded at C$0.48, with a volume of 497505 shares. The stock had previously closed at C$0.44.

The company has a market capitalization of $55.59 million and a PE ratio of -15.00.

Get Theralase Technologies alerts:

TRADEMARK VIOLATION WARNING: “Theralase Technologies (TLT) Hits New 52-Week High at $0.50” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/4158304/theralase-technologies-tlt-hits-new-52-week-high-at-0-50.html.

Theralase Technologies Company Profile (CVE:TLT)

Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Photo Dynamic Therapy and Therapeutic Laser Technology.

Recommended Story: Understanding Stock Ratings